App-assisted self-management of hypertensio

Not Applicable

• Conditions: I10; I11; I12; I13; Essential (primary) hypertension; Hypertensive heart disease; Hypertensive renal disease; Hypertensive heart and renal disease

• Registration Number: DRKS00027964
• Lead Sponsor: Pathmate Technologies GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-31
• Study Completion: 2023-09-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 606

Inclusion Criteria

Diagnosis of hypertension/arterial hypertension (e.g. ICD 10: i10, i11, i12, i13)
- Sufficient knowledge of German
- Existing e-mail address
- Internet access
- Smartphone ownership

Exclusion Criteria

- The Manoa app has already been used in the past
- Pregnancy
- There is a severe (non-correctable) visual impairment that may affect the use of the app

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference in reduction of systolic blood pressure (office blood pressure measurement) from time t0 to time t1 (routine follow-up after 90-150 days) between control and intervention group for patients with uncontrolled blood pressure (office blood pressure measurement >= 140 mmHg).